← FDA Drug Approvals (Drugs@FDA)
BECLOMETHASONE DIPROPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROLIFE PHARMA LLC · Approved 2026-09-14
Drug application
- FDA Application #
ANDA214418- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BECLOMETHASONE DIPROPIONATE
- Generic name
- Beclomethasone Dipropionate
- Active ingredients
- BECLOMETHASONE DIPROPIONATE
- Dosage form
- AEROSOL, METERED
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- AUROLIFE PHARMA LLC
- First approval
- 2026-09-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown